MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Genocea Biosciences Company Profile (NASDAQ:GNCA)

Consensus Ratings for Genocea Biosciences (NASDAQ:GNCA) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.00 (35.87% upside)

Analysts' Ratings History for Genocea Biosciences (NASDAQ:GNCA)
Show:
DateFirmActionRatingPrice TargetActions
5/20/2015FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Piper JaffrayReiterated RatingOverweight$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Needham & Company LLCSet Price TargetBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015FBR & Co.Initiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Piper JaffrayInitiated CoverageOverweight$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Stifel NicolausReiterated RatingPositive -> Buy$29.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2014Needham & Company LLCInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Stifel NicolausInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Citigroup Inc.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2013 forward)